Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
(https://silviresearch.com/ ) Institution: University of Nottingham - AstraZeneca Start date: Oct 2024 Project description An iCASE 4-year PhD studentship is currently available in the Silvi research group
-
in your group, across the LMB and with external collaborators at AstraZeneca and the CNR, Milan. Person Specification 1 Academic qualifications and experience: PhD in a relevant subject or a Master's
-
of Cambridge under the supervision of Professors Heike Laman and Kathryn Lilley, and Dr Monica Rodrigo at AstraZeneca. Scientific area Targeted Protein Degradation (TPD) is a new therapeutic modality that makes
-
. of Cambridge and the new AstraZeneca Discovery Centre at Cambridge. The student will be working on a collaborative project jointly supervised by Dr Mennella in in the MRC Toxicology Unit and Dr Emma Rawlins in
-
microscopy and other biophysical methods to troubleshoot and optimise fluorescence-based assays that can be used for high-throughput compound screening at AstraZeneca. The project is funded by a Medical
-
supervisors. The PhD studentship is jointly supervised by Professor Michael Inouye and Dr Scott Ritchie. Research Environment: The PhD studentship will be hosted at the Department of Public Health and Primary
-
including Heptares Therapeutics and Galapagos NV, as well as consolidating links to the pharmaceutical giant AstraZeneca, resulting in enhanced funding and joint publications. By linking small molecule